Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells

Cancer Biology and Therapy

Volumn 12, Issue 8, 2011, Pages 718-726

  Irwin, Mary E ^a   Bohin, Natacha ^b   Boerner, Julie L ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Akt; Breast cancer; c Src; Cholesterol; Crosstalk; Epidermal growth factor receptor; Lipid rafts

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CELL ACTIVATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; LIPID RAFT; MOUSE; NONHUMAN; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DRUG SYNERGISM; FEMALE; HUMANS; MEMBRANE MICRODOMAINS; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 80054115932     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.8.16907     Document Type: Article

References (52)

1. Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 2006; 125:1137-49; PMID:16777603; DOI:10.1016/j.cell.2006.05.013.
2. Jorissen RN, Walker F, Pouliot N, Garrett TP, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003; 284:31-53; PMID:12648464; DOI:10.1016/S0014-4827(02)00098-8.
3. Boerner JL, Demory ML, Silva C, Parsons SJ. Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol Cell Biol 2004; 24:7059-71; PMID:15282306; DOI:10.1128/MCB.24.16.7059-71.2004.
4. Cohen S, Fava RA. Internalization of functional epidermal growth factor:receptor/kinase complexes in A-431 cells. J Biol Chem 1985; 260:12351-8; PMID:2995372.
5. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001; 3:802-8; PMID:11533659; DOI:10.1038/ncb0901-802.
6. Wu W, Graves LM, Gill GN, Parsons SJ, Samet JM. Src-dependent phosphorylation of the epidermal growth factor receptor on tyrosine 845 is required for zinc-induced Ras activation. J Biol Chem 2002; 277:24252-7; PMID:11983694; DOI:10.1074/jbc.M200437200.
7. Chen X, Resh MD. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J Biol Chem 2002; 277:49631-7; PMID:12397069; DOI:10.1074/jbc.M208327200.
8. Ringerike T, Blystad FD, Levy FO, Madshus IH, Stang E. Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae. J Cell Sci 2002; 115:1331-40; PMID:11884532.
9. Roepstorff K, Thomsen P, Sandvig K, van Deurs B. Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding. J Biol Chem 2002; 277:18954-60; PMID:11886870; DOI:10.1074/jbc. M201422200.
10. Westover EJ, Covey DF, Brockman HL, Brown RE, Pike LJ. Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. Studies with cholesterol enantiomers. J Biol Chem 2003;278:51125-33; PMID:14530278; DOI:10.1074/jbc. M304332200.
11. Lisanti MP, Tang Z, Scherer PE, Kubler E, Koleske AJ, Sargiacomo M. Caveolae, transmembrane signalling and cellular transformation. Mol Membr Biol 1995; 12:121-4; PMID:7767370; DOI:10.3109/09687689509038506.
12. Wu C, Butz S, Ying Y, Anderson RG. Tyrosine kinase receptors concentrated in caveolae-like domains from neuronal plasma membrane. J Biol Chem 1997; 272:3554-9; PMID:9013605; DOI:10.1074/jbc.272.6.3554.
13. Hope HR, Pike LJ. Phosphoinositides and phosphoinositide-utilizing enzymes in detergent-insoluble lipid domains. Mol Biol Cell 1996; 7:843-51; PMID:8816992.
14. Danielsen EM, van Deurs B. A transferrin-like GPI-linked iron-binding protein in detergent-insoluble noncaveolar microdomains at the apical surface of fetal intestinal epithelial cells. J Cell Biol 1995; 131:939-50; PMID:7490295; DOI:10.1083/jcb.131.4.939.
15. Sargiacomo M, Scherer PE, Tang Z, Kubler E, Song KS, Sanders MC, et al. Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc Natl Acad Sci USA 1995; 92:9407-11; PMID:7568142; DOI:10.1073/pnas.92.20.9407.
16. Zajchowski LD, Robbins SM. Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains. Eur J Biochem 2002; 269:737-52; PMID:11846775; DOI:10.1046/j.0014-2956.2001.02715.x.
17. Arcaro A, Aubert M, Espinosa del Hierro ME, Khanzada UK, Angelidou S, Tetley TD, et al. Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling. Cell Signal 2007; 19:1081-92; PMID:17275257; DOI:10.1016/j.cellsig.2006.12.003.
18. Sigal CT, Zhou W, Buser CA, McLaughlin S, Resh MD. Amino-terminal basic residues of Src mediate membrane binding through electrostatic interaction with acidic phospholipids. Proc Natl Acad Sci USA 1994; 91:12253-7; PMID:7527558; DOI:10.1073/pnas.91.25.12253.
19. Kasai A, Shima T, Okada M. Role of Src family tyrosine kinases in the downregulation of epidermal growth factor signaling in PC12 cells. Genes Cells 2005; 10:1175-87; PMID:16324154; DOI:10.1111/j.1365-2443.2005.00909.x.
20. Mukherjee A, Arnaud L, Cooper JA. Lipid-dependent recruitment of neuronal Src to lipid rafts in the brain. J Biol Chem 2003; 278:40806-14; PMID:12912979; DOI:10.1074/jbc.M306440200.
21. Shenoy-Scaria AM, Gauen LK, Kwong J, Shaw AS, Lublin DM. Palmitylation of an amino-terminal cysteine motif of protein tyrosine kinases p56lck and p59fyn mediates interaction with glycosyl-phosphatidylinositol-anchored proteins. Mol Cell Biol 1993; 13:6385-92; PMID:8413237.
22. Luttrell DK, Luttrell LM, Parsons SJ. Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src. Mol Cell Biol 1988; 8:497-501; PMID:2447487.
23. Weernink PA, Rijksen G. Activation and translocation of c-Src to the cytoskeleton by both platelet-derived growth factor and epidermal growth factor. J Biol Chem 1995; 270:2264-7; PMID:7530720; DOI:10.1074/jbc.270.5.2264.
24. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 1999; 274:8335-43; PMID:10075741; DOI:10.1074/jbc.274.12.8335.
25. Sato K, Sato A, Aoto M, Fukami Y. Site-specific association of c-Src with epidermal growth factor receptor in A431 cells. Biochem Biophys Res Commun 1995; 210:844-51; PMID:7539262; DOI:10.1006/bbrc.1995.1735.
26. Stover DR, Becker M, Liebetanz J, Lydon NB. Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and P85 alpha. J Biol Chem 1995; 270:15591-7; PMID:7797556; DOI:10.1074/jbc.270.26.15591.
27. Maa MC, Leu TH, McCarley DJ, Schatzman RC, Parsons SJ. Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. Proc Natl Acad Sci USA 1995; 92:6981-5; PMID:7542783; DOI:10.1073/pnas.92.15.6981.
28. Tice DA, Biscardi JS, Nickles AL, Parsons SJ. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci USA 1999; 96:1415-20; PMID:9990038; DOI:10.1073/pnas.96.4.1415.
29. Dimri M, Naramura M, Duan L, Chen J, Ortega-Cava C, Chen G, et al. Modeling breast cancer-associated c-Src and EGFR overexpression in human MECs: c-Src and EGFR cooperatively promote aberrant three-dimensional acinar structure and invasive behavior. Cancer Res 2007; 67:4164-72; PMID:17483327; DOI:10.1158/0008-5472.CAN-06-2580.
30. Irwin ME, Mueller KL, Bohin N, Ge Y, Boerner JL. Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. J Cell Physiol 2010; PMID:21140447.
31. Oh HY, Lee EJ, Yoon S, Chung BH, Cho KS, Hong SJ. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction. Prostate 2007; 67:1061-9; PMID:17469127; DOI:10.1002/pros.20593.
32. Wolf AA, Jobling MG, Wimer-Mackin S, Ferguson-Maltzman M, Madara JL, Holmes RK, et al. Ganglioside structure dictates signal transduction by cholera toxin and association with caveolae-like membrane domains in polarized epithelia. J Cell Biol 1998; 141:917-27; PMID:9585411; DOI:10.1083/jcb.141.4. 917.
33. Mueller KL, Yang ZQ, Haddad R, Ethier SP, Boerner JL. EGFR/Met association regulates EGFR TKI resistance in breast cancer. J Mol Signal 2010; 5:8; PMID:20624308; DOI:10.1186/1750-2187-5-8.
34. Kim LC, Rix U, Haura EB. Dasatinib in solid tumors. Expert Opin Investig Drugs 2010; 19:415-25; PMID:20113198; DOI:10.1517/13543781003592097.
35. Robbins SM, Quintrell NA, Bishop JM. Myristoylation and differential palmitoylation of the HCK protein-tyrosine kinases govern their attachment to membranes and association with caveolae. Mol Cell Biol 1995; 15:3507-15; PMID:7791757.
36. Shenoy-Scaria AM, Dietzen DJ, Kwong J, Link DC, Lublin DM. Cysteine3 of Src family protein tyrosine kinase determines palmitoylation and localization in caveolae. J Cell Biol 1994; 126:353-63; PMID:7518463; DOI:10.1083/jcb.126.2. 353.
37. Stoddart A, Dykstra ML, Brown BK, Song W, Pierce SK, Brodsky FM. Lipid rafts unite signaling cascades with clathrin to regulate BCR internalization. Immunity 2002; 17:451-62; PMID:12387739; DOI:10.1016/S1074-7613(02)00416-8.
38. Smythe GM, Eby JC, Disatnik MH, Rando TA. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes. J Cell Sci 2003; 116:4739-49; PMID:14600260; DOI:10.1242/jcs.00806.
39. Nair VD, Sealfon SC. Agonist-specific transactivation of phosphoinositide-3-kinase signaling pathway mediated by the dopamine D2 receptor. J Biol Chem 2003; 278:47053-61; PMID:12970364; DOI:10.1074/jbc. M303364200.
40. Mueller KL, Hunter LA, Ethier SP, Boerner JL. Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells. Cancer Res 2008; 68:3314-22; PMID:18451158; DOI:10.1158/0008-5472.CAN-08-0132.
41. Hur EM, Park YS, Lee BD, Jang IH, Kim HS, Kim TD, et al. Sensitization of epidermal growth factor-induced signaling by bradykinin is mediated by c-Src. Implications for a role of lipid microdomains. J Biol Chem 2004; 279:5852-60; PMID:14630916; DOI:10.1074/jbc.M311687200.
42. Jeon JH, Kim SK, Kim HJ, Chang J, Ahn CM, Chang YS. Lipid raft modulation inhibits NSCLC cell migration through delocalization of the focal adhesion complex. Lung Cancer 2010; 69:165-71; PMID:19945766; DOI:10.1016/j.lungcan.2009. 10.014.
43. Biscardi JS, Tice DA, Parsons SJ. c-Src, receptor tyrosine kinases and human cancer. Adv Cancer Res 1999; 76:61-119; PMID:10218099; DOI:10.1016/S0065-230X(08)60774-5.
44. Johns TG, Perera RM, Vernes SC, Vitali AA, Cao DX, Cavenee WK, et al. The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status and heterodimerization. Clin Cancer Res 2007; 13:1911-25; PMID:17363548; DOI:10.1158/1078-0432.CCR-06-1453.
45. Andersen P, Villingshoj M, Poulsen HS, Stockhausen MT. Improved response by co-targeting EGFR/EGFRvIII and Src family kinases in human cancer cells. Cancer Invest 2009; 27:178-83; PMID:19235590; DOI:10.1080/07357900802570759.
46. Koppikar P, Choi SH, Egloff AM, Cai Q, Suzuki S, Freilino M, et al. Combined inhibition of c-Src and epidermal growth factor receptor abrogates growth and invasion of head and neck squamous cell carcinoma. Clin Cancer Res 2008; 14:4284-91; PMID:18594011; DOI:10.1158/1078-0432.CCR-07-5226.
47. Haura EB, Tanvetyanon T, Chiappori A, Williams C, Simon G, Antonia S, et al. Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer. J Clin Oncol 2010; 28:1387-94; PMID:20142592; DOI:10.1200/JCO.2009.25.4029.
48. Lombardo LJ, Lee FY, Chen P, Norris D, Barrish JC, Behnia K, et al. Discovery of N-(2-Chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1- yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays. J Med Chem 2004; 47:6658-61; PMID:15615512; DOI:10.1021/jm049486a.
49. Baillat G, Siret C, Delamarre E, Luis J. Early adhesion induces interaction of FAK and Fyn in lipid domains and activates raft-dependent Akt signaling in SW480 colon cancer cells. Biochem Biophys Acta 2008; 1783:2323-31; PMID:18805444; DOI:10.1016/j.bbamcr.2008.08.008.
50. Donepudi M, Resh MD. c-Src trafficking and co-localization with the EGF receptor promotes EGF ligand-independent EGF receptor activation and signaling. Cell Signal 2008; 20:1359-67; PMID:18448311; DOI:10.1016/j.cellsig.2008.03.007.
51. Macdonald JL, Pike LJ. A simplified method for the preparation of detergent-free lipid rafts. J Lipid Res 2005; 46:1061-7; PMID:15722565; DOI:10.1194/jlr.D400041-JLR200.
52. Liu Y, Sun R, Wan W, Wang J, Oppenheim JJ, Chen L, et al. The involvement of lipid rafts in epidermal growth factor-induced chemotaxis of breast cancer cells. Mol Membr Biol 2007; 24:91-101; PMID:17453416; DOI:10.1080/ 10929080600990500.